Biotechnology company successfully secures equity fundraising investment

 Biotechnology company successfully secures equity fundraising investment

A UK-based Biotechnology company successfully secured an equity fundraising investment earlier this year, in a deal advised on by GS Verde Group.

Founded in 2017, the company design, produce & test novel biomaterials through a sustainable process and offer bespoke services. As a result of the successful equity, the company will benefit from having access to capital, gain further knowledge from experienced stakeholders and maintain the function of its daily business operations.

Equity funding is an excellent way for businesses to raise capital and offers a wide variety of options such as Venture Capital, Angel Investors and Private Equity.

Angel Investors offer financial support and industry insights to new businesses, which is invaluable when seeking a way to become established in a particular industry.

Venture Capital is also a beneficial route for businesses to take, particularly those that are potentially high growth, and for business owners looking for ways to enhance their business' financial status. This avenue provides funding and strategic guidance to help companies accelerate their expansion goals for long-term success and help drive future profitability.

For businesses looking for larger-scale investments, Private Equity presents a strong opportunity for long-term growth. This entails firms investing large amounts of capital into businesses to support growth initiatives such as expansions or restructuring. Private Equity sets itself apart from the other funding options as it combines capital with hands-on expertise, allowing businesses to scale efficiently while enhancing their operations.

At GS Verde Group, our team plays a critical role in guiding you through a successful transaction - from managing the due diligence process to connecting your business with the right investors. Our multi-discipline team have the expertise to help your business achieve your equity funding goals, and help you secure the right type of investment for long-term success.

GS Verde Group were pleased to support the Biotechnology company throughout the equity investment deal, and provide end-to-end expert advice to ensure its' growth strategy success.

The GS Verde Group are business-focused experts in getting deals done. Combining all the services needed to complete a corporate transaction, including legal, corporate finance, tax, accountancy and communications, GS Verde Group acts as a complete advisory team and provides a truly end-to-end service.